DUBLIN--(BUSINESS WIRE)--The "At-home Self Testing Kits Market Distribution by Type of Test Format, Type of Biofluid Analyzed Therapeutic Area and Key Geographical Regions, Europe, Asia-Pacific, Africa and South America): Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
This report features an extensive study of the current market landscape and future potential associated with the at-home self-testing kits market. The study also includes an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.
Since the approval of the first over-the-counter test kits in the early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US.
Companies have also developed at-home diagnostic kits for the detection and diagnosis of various diseases, such as human immunodeficiency virus (HIV) infection, diabetes, Hepatitis C, colon cancer and COVID-19. Specifically, post the onset of COVID-19, there has been an upsurge in the demand for self-testing kits.
In fact, in 2021, more than 100 at-home self-testing kits were approved by the USFDA for the diagnosis of COVID-19. The popularity of these kits can be attributed to the fact that they are more reliable, efficient, high yielding, as well as compatible with a broad range of input samples, including blood, cells, tissues, plasma, saliva and microbes.
Given the extensive utilization of at-home testing kits in the diagnosis of a myriad of disease indications, there has been a significant rise in investments in this domain. Over USD 2.2 billion has been invested in this domain by various government institutions in the US, over the last five years.
Further, the current market landscape is consolidated and primarily dominated by the kits being developed to detect pregnancies, monitoring glucose and ovulation patterns. We believe that, with an increase in the number of point-of-care test kits being developed across various therapeutic areas, such as infectious diseases and celiac diseases, and their subsequent commercialization, the opportunities for self-testing kit developers is likely to increase in the foreseen future.
At present, efforts are also ongoing to connect at-home diagnostic tests with telemedicine; this is expected to enable a rapid turnaround time. The ongoing innovations in this market are anticipated to bring a positive revolution in the healthcare domain. Given the continuous efforts being undertaken by industry players, the at-home self-testing kits market is poised to witness healthy growth over the next decade.
One of the key objectives of the report was to estimate the current opportunity and future size of at-home self-testing kits market. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, over the period 2022-2035.
Companies Mentioned
- Abbott Diabetes Care (A Subsidiary of Abbott)
- ACON Laboratories
- AdvaCare Pharma
- Agera Health
- Alfa Scientific Designs
- Ameritek
- ApexBio
- Arizona State University
- ARKRAY
- Artron Laboratories
- Ascensia Diabetes Care
- Atomo Diagnostics
- Auburn University
- Bionime
- Biosynex
- Biotron Diagnostics
- Boston University Medical Campus
- Brigham Young University
- Brown University
- Calpro (Acquired by Svar Life Sciences)
- Carnegie Mellon University
- Case Western Reserve University
- CEI Technology
- Central Michigan University
- Chembio Diagnostics
- Clarity Diagnostics
- Cnoga Medical
- Colorado State University
- Columbia University Health Sciences
- CommonSense (Acquired by Peptonic Medical)
- Confirm Biosciences
- Cornell University
- Delfran Pharmaceuticals
- DNX Medical
- Drexel University
- Duke University
- e-LinkCare Meditech
- Emory University
- EPS biotechnology
- Florida International University
- ForaCare
- GE Healthcare
- Genlantis Diagnostics
- Georgetown University
- Georgia State University
- Germaine Laboratories
- GlucoMe
- iHealth Labs
- i-SENS
- Johns Hopkins University
- Johnson & Johnson
- And Many More Companies!
Key Questions Answered
- Who are the leading players engaged in the manufacturing of at-home self-testing kits?
- What is the most common diagnostic assay offered by at-home self-testing kit manufacturers?
- What are the key regulatory frameworks for at-home self-testing kits across different geographical regions?
- Which companies / institutes have received grants for the research and development of at-home self-testing kits?
- What are the key factors influencing the price of at-home self-testing kits?
- What is the likely valuation / net worth of companies engaged in this domain?
- What is the current, global demand for at-home self-test kits?
- How is the current and future market opportunity likely to be distributed across key market segments?
- What is the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments?
Key Topics Covered:
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. MARKET OVERVIEW
5. GRANTS ANALYSIS
6. COMPANY COMPETITIVENESS ANALYSIS
7. COMPANY PROFILES
8. BOWMAN CLOCK PRICING STRATEGY
9. COMPANY COMPARABLE ANALYSIS
10. DEMAND ANALYSIS
11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12. ATTRACTIVENESS COMPETITIVENESS MATRIX
13. CONCLUDING REMARKS
14. INTERVIEW TRANSCRIPTS
15. APPENDIX I: TABULATED DATA
16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For more information about this report visit https://www.researchandmarkets.com/r/2wly2m.
